(Q63818473)
Statements
ARI114694 (English)
0 references
An Open-label, Randomized, Single Dose, Two-Period Crossover Study to Determine the Bioavailability of a Fixed Dose Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5mg/0.2mg) Relative to Co-administration of Dutasteride 0.5mg Capsules and Tamsulosin Hydrochloride 0.2mg (English)
0 references
10 September 2010
0 references
21 December 2010
0 references
86
0 references
20 year
0 references
45 year
0 references